Cipla Limited (CIPLA) Share Analysis
NSE · Healthcare · Pharmaceuticals
Cipla Limited (NSE: CIPLA) is an Indian listed company in the Pharmaceuticals sector and a constituent of NIFTY 100, NIFTY 200, NIFTY 50. As of 14 Nov 2026, the share price was ₹1,392.00, P/E 36.2, ROE 11.6%.
Get the AI verdict on CIPLA: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
CIPLA chart with trendlines
Is CIPLA a buy right now?
Sign in free for the AI verdict with entry zone, targets and stop-loss.
About Cipla Limited
Stored fundamentals as of 14 Nov 2026 — not a live quote. Signed-in analysis uses same-day data.
CIPLA key facts
| Price and valuation | |
|---|---|
| Share price | ₹1,392.00 |
| Market cap | ₹1.12L Cr |
| P/E ratio | 36.2 |
| P/B ratio | 3.18 |
| EPS | ₹35.87 |
| Book value per share | ₹438.00 |
| Dividend yield | 0.93% |
| 52-week range | |
| 52-week high | ₹1,539.70 |
| 52-week low | ₹1,165.70 |
| Face value | ₹2.00 |
| Shareholding pattern | |
| Promoters | 29.2% |
| FIIs | 20.24% |
| DIIs | 34.61% |
| Public | 15.6% |
Index membership: NIFTY 100, NIFTY 200, NIFTY 50, NIFTY 500, NIFTY Healthcare Index, NIFTY Pharma.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.